| Model Number |
B1080-040 |
| Medical Device Problem Codes |
Material Rupture (1546); Improper or Incorrect Procedure or Method (2017)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
10/13/2022
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
(b)(4).The device was received.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
|
| |
|
Event or Problem Description
|
|
It was reported that the procedure was to treat the left common iliac artery with mild calcification and no tortuosity.The armada 35 balloon dilatation catheter (bdc) ruptured at 14 atmospheres (atms) during the first inflation.The device was not prepared (air aspiration) outside of the body prior to use.There was no adverse patient effect and there was no clinically significant delay in the procedure.No additional information was provided.
|
| |
|
Additional Manufacturer Narrative
|
|
Visual inspection was performed on the returned device.The reported balloon rupture was confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents and/or complaints from this lot.It was reported that the device was not prepared (air aspiration) outside the anatomy.It should be noted that the percutaneous transluminal angioplasty (pta) armada 35 / armada 35 ll, global, instruction for use (ifu) indicates to perform the steps to remove all air and verify the integrity of the pta catheter.Leave the catheter under negative pressure until the balloon is at the target lesion site.Then the device can be introduced into the vascular system.In this case, it is unknown if the violation of the ifu caused or contributed to the reported complaint.The investigation determined the reported balloon rupture appears to be related to operational context.There is no indication of a product quality issue with respects to the design, manufacture, or labeling of the device.
|
| |
|
Search Alerts/Recalls
|